11
Participants
Start Date
August 31, 2006
Primary Completion Date
August 31, 2007
Study Completion Date
April 30, 2010
Sirolimus
Immunosuppressant beginning day -3 with 12 mg oral loading dose, 4 mg/day orally for adults
MMF
Immunosuppressant given through IV on day 0 at 15 mg/kg twice daily ≥ 2hr after the completion for the donor cell infusion
BCNU
15 mg/kg, IV
VP-16
60 mg/kg, IV
CY
For subjects aged 18-60 with lymphoma 100 mg/kg, IV For subjects aged with AML, ALL or CML 18-50 60 mg/kg, IV For subjects aged 51-60 with MDS, AML or ALL or patients age 18-60 with MDS, secondary AML or non-CML myeloproliferative disease 45 mg/kg
FTBI
1320 cGy delivered in 11 120 cGy fractions over 4 day
BU
BU 1 mg/kg every 6hr x 4 doses, IV
Stanford University School of Medicine, Stanford
Stanford University
OTHER